Literature DB >> 18653649

Metabonomic analysis of exhaled breath condensate in adults by nuclear magnetic resonance spectroscopy.

G de Laurentiis1, D Paris, D Melck, M Maniscalco, S Marsico, G Corso, A Motta, M Sofia.   

Abstract

Exhaled breath condensate (EBC) is a noninvasive method for the study of airway lining fluid. Nuclear magnetic resonance (NMR) spectroscopy can provide biochemical profiles of metabolites in biological samples. The aim of the present study was to validate the NMR metabonomic analysis of EBC in adults, assessing the role of pre-analytical variables (saliva and disinfectant contamination) and the potential clinical feasibility. In total, 36 paired EBC and saliva samples, obtained from healthy subjects, laryngectomised patients and chronic obstructive pulmonary disease patients, were analysed by means of (1)H-NMR spectroscopy followed by principal component analysis. The effect on EBC of disinfectant, used for reusable parts of the condenser, was assessed after different washing procedures. To evaluate intra-day repeatability, eight subjects were asked to collect EBC and saliva twice within the same day. All NMR saliva spectra were significantly different from corresponding EBC samples. EBC taken from condensers washed with recommended procedures invariably showed spectra perturbed by disinfectant. Each EBC sample clustered with corresponding samples of the same group, while presenting intergroup qualitative and quantitative signal differences (94% of the total variance within the data). In conclusion, the nuclear magnetic resonance metabonomic approach could identify the metabolic fingerprint of exhaled breath condensate in different clinical sets of data. Moreover, metabonomics of exhaled breath condensate in adults can discriminate potential perturbations induced by pre-analytical variables.

Entities:  

Mesh:

Year:  2008        PMID: 18653649     DOI: 10.1183/09031936.00072408

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  24 in total

Review 1.  Mapping targetable inflammation and outcomes with cystic fibrosis biomarkers.

Authors:  Olivia Giddings; Charles R Esther
Journal:  Pediatr Pulmonol       Date:  2017-07-17

2.  Metabolomic profiles of plasma, exhaled breath condensate, and saliva are correlated with potential for air toxics detection.

Authors:  Chandresh Nanji Ladva; Rachel Golan; Roby Greenwald; Tianwei Yu; Stefanie Ebelt Sarnat; W Dana Flanders; Karan Uppal; Douglas I Walker; ViLinh Tran; Donghai Liang; Dean P Jones; Jeremy A Sarnat
Journal:  J Breath Res       Date:  2017-12-06       Impact factor: 3.262

3.  Metabolomics analysis identifies novel plasma biomarkers of cystic fibrosis pulmonary exacerbation.

Authors:  Theresa A Laguna; Cavan S Reilly; Cynthia B Williams; Cole Welchlin; Chris H Wendt
Journal:  Pediatr Pulmonol       Date:  2015-06-26

4.  Metabolomic Evaluation of Neutrophilic Airway Inflammation in Cystic Fibrosis.

Authors:  Charles R Esther; Raymond D Coakley; Ashley G Henderson; Yi-Hui Zhou; Fred A Wright; Richard C Boucher
Journal:  Chest       Date:  2015-08       Impact factor: 9.410

Review 5.  Integrating omics technologies to study pulmonary physiology and pathology at the systems level.

Authors:  Ravi Ramesh Pathak; Vrushank Davé
Journal:  Cell Physiol Biochem       Date:  2014-04-28

6.  Pharmacotherapy of patients with mild persistent asthma: strategies and unresolved issues.

Authors:  Paolo Montuschi
Journal:  Front Pharmacol       Date:  2011-07-14       Impact factor: 5.810

Review 7.  Isoprostanes-biomarkers of lipid peroxidation: their utility in evaluating oxidative stress and analysis.

Authors:  Monika Janicka; Agata Kot-Wasik; Jacek Kot; Jacek Namieśnik
Journal:  Int J Mol Sci       Date:  2010-11-17       Impact factor: 5.923

Review 8.  Exploring airway diseases by NMR-based metabonomics: a review of application to exhaled breath condensate.

Authors:  Matteo Sofia; Mauro Maniscalco; Guglielmo de Laurentiis; Debora Paris; Dominique Melck; Andrea Motta
Journal:  J Biomed Biotechnol       Date:  2011-03-15

9.  Significance of bioinformatics in research of chronic obstructive pulmonary disease.

Authors:  Hong Chen; Xiangdong Wang
Journal:  J Clin Bioinforma       Date:  2011-12-20

10.  Metabonomic profiling of serum and urine by (1)H NMR-based spectroscopy discriminates patients with chronic obstructive pulmonary disease and healthy individuals.

Authors:  Lingling Wang; Yufu Tang; Shuo Liu; Shitao Mao; Yuan Ling; Dan Liu; Xiaoyu He; Xiaoge Wang
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.